Analysis of Four Large Post-Marketing Surveillance Studies Describe Clinical Effects of Sucrose-Formulated Recombinant Factor VIII
BOSTON, July 13 /PRNewswire/ -- New data pooled from four large, "real world" post-marketing surveillance studies showed that sucrose-formulated recombinant factor
VIII (rFVIII-FS) reduced bleeding and provided data regarding adverse events in more than 950 patients with mild-to-severe hemophilia ...
FDA Approves New 3000 IU Vial Size for Kogenate(R) FS, antihemophilic factor (recombinant)
...or safe reconstitution and fast recombinant factor
viii treatment in a small, tamper-evident box with anti...lic factor (recombinant) , is a recombinant factor
viii treatment indicated for the control and prevention...hilia A
Hemophilia A, also known as factor
viii deficiency or classic hemophilia, is largely an in...
Bayer HealthCare Announces Recipients of 2009 International Hemophilia Nursing Fellowship
... and Thailand to Australia and Argentina. For more information visit: www.wfh.org .
About Hemophilia A
Hemophilia A, also known as factor
viii deficiency or classic hemophilia, is largely an inherited bleeding disorder in which one of the proteins needed to form blood clots in the body is mis...
Bayer HealthCare Awards $2.5 Million to Advance Hemophilia Research and Improve Patient Care
... to develop neutralizing antibodies (inhibitors) against replacement Factor
viii proteins. In another study, Early Career Investigator Award recipient Micha...wards.com .
About Hemophilia A
Hemophilia A, also known as factor
viii deficiency or classic hemophilia, is largely an inherited bleeding disorder...
Bayer HealthCare Launches Hemophilia Self-Infusion Training Program
...ve designed to make infusion of recombinant factor
viii easier for both patients with hemophilia A and for...educed levels of the blood clotting protein factor
viii leading to prolonged or uncontrolled bleeding epis...of this disease may require the infusion of factor
viii therapy sometimes once, twice or three times per w...
Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products
...digit royalties on sales of products resulting from the collaboration.
"This collaboration serves as an excellent fit with our recombinant Factor
viii and Factor IX hemophilia products and provides us with an opportunity to expand Wyeth's hemophilia franchise," says Mikael Dolsten, President, Wyeth R...
Strides Made in Hemophilia Research
...tic gene become inserted into the genome of the targeted cells.
Fifty weeks after the treatment, mice injected with these nanoparticles had Factor
viii levels that were the same as those of normal mice. Bleeding times were also similar to those of normal mice.
According to a news release from the j...
Experts reach consensus on diagnosis and treatment of bleeding disorders in women
...ults from a deficiency in, or a dysfunction of, von Willebrand factor (VWF), a protein necessary for normal platelet adhesion and protection of factor
viii (FVIII) from proteolysis in the circulation. The prevalence of menorrhagia in women with VWD is 74-92%.
Although the majority of women who present ...
Patient Convenience Focus of New Upgrades to HeliTrax System by CSL Behring
...fective blood coagulation proteins known as factor
viii or factor IX. The most common form of the disease ...classical hemophilia, in which the clotting factor
viii is either deficient or defective. Hemophilia B is ...t Helixate FS
Helixate FS is a recombinant factor
viii product indicated for the treatment of hemophilia ...
CSL Behring Marks World Hemophilia Day with $2M Coagulation Factor Donation to World Federation of Hemophilia
...L Behring has committed to donating to WFH two (2) million units of factor
viii concentrate (FVIII) each year for the next three (3) years. The donation, t...very pleased to announce it on World Hemophilia Day 2009."
Factor
viii is an essential blood clotting factor. FVIII is concentrated from donated b...
VIII in Medical Technology
Clinical Data Suggest Decreased Bleeding Risk in People With Severe
Hemophilia A While Maintaining Factor VIII Levels Above One Percent
Results Highlighted in Oral Presentation at International Symposium
of Thrombosis and Haemostasis
GENEVA, July 10, 2007 /PRNewswire-FirstCall/ -- Baxter
Healthcare Corporation today announced the presentation of findings
from the ADAPT (Analysis of Data from ADVATE(R) Prospective Trials)
study pro...
Inspiration Biopharmaceuticals, Inc. Initiates Phase 1 Clinical Trial of IB1001 for the Treatment of Hemophilia B
...xcess of seven billion dollars annually. There are two types of hemophilia, hemophilia A and hemophilia B. Hemophilia A is caused by a lack of Factor
viii and hemophilia B is caused by a deficiency of Factor IX.
About Inspiration Biopharmaceuticals
Inspiration Biopharmaceuticals was founded in ...
Jennerex Treats First Patients in Phase 2 JX-594 Trial for Liver Cancer
...tis B (Hepavax), the first Epidemic Hemorrhagic Fever vaccine and the
world's second chicken pox vaccine. Green Cross is developing recombinant
Factor
viii and Factor IX for hemophilia, Hepatitis B Immunoglobulin
monoclonal antibody for liver transplantation, anticancer drugs such as
Greenstatin (anti-ang...
Pivotal Phase III Data Confirm the Efficacy and Safety of Arpida's Intravenous Iclaprim in Treating Patients With Complicated Skin and Skin Structure Infections
... MRSA Surveillance Summary 2007. Available at http://www.cdc.gov/ncidod/dhqp/ar_mrsa_surveillanceFS.html . Accessed October 22, 2008.
viii Kuehnert MJ et al. Emerging Infectious Diseases 2005; 11: 868-72. ix Klevens, RM et al. Journal of the American Medical Association. 2007;...
FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A
...roval provides these patients
with the only factor
viii treatment that the FDA has determined safe and
eff...he FDA approval of Kogenate FS as the first factor
viii treatment
product in the U.S. to be used to replenish factor
viii levels in a
prophylactic manner marks a significan...
Bayer HealthCare Celebrates 20th Anniversary of Kogenate(R) Product Line and 8 Billion IU Milestone at 2008 WFH World Congress
...n Bonn, Germany. This
advent of recombinant factor
viii technology represented a leap forward in
the deliv...only company with a
long-acting recombinant factor
viii protein in human clinical trials. We
are also crea...ilic Factor [Recombinant]) is a recombinant
factor
viii treatment indicated for the treatment of hemophili...
Catalyst Biosciences Selects Drug Development Candidate in Factor VIIa Program for Hemophilia
...ficiency of a protein required for normal blood
coagulation, such as factor
viii (hemophilia A) or factor IX (hemophilia B)
in addition to factor VIIa for r...umber of hemophilia A patients develop
inhibitory antibodies against factor
viii and therefore become refractory
to this treatment. These patients are then ...
Inspiration Biopharmaceuticals Announces Filing of IND for Novel Recombinant Factor IX Product, IB1001, for the Treatment of Hemophilia B
...which only 25% currently receive therapy. There are two types of
hemophilia, hemophilia A and hemophilia B. Hemophilia A is caused by a lack
of Factor
viii and hemophilia B is caused by a deficiency of Factor IX. About Recombinant Protein Manufacturing Technology Inspiration Biopharmaceuticals uses nove...
Neose Announces Presentation of Positive Preclinical Data on
GlycoPEGylated Factor VIIa at the XXI Congress of the International
Society on Thrombosis and Haemostasis
...and for the prevention of bleeding during surgery or invasive
procedures in patients with congenital hemophilia with inhibitors
to coagulation factors
viii or IX. The worldwide market for
recombinant Factor VII was approximately $1 billion in 2006, with
Novo Nordisk being the only participant.
About Neo...
Prothrombin Time Comes in Small (CLIA-Waived) Packages
... levels is necessary to plan or evaluate anticoagulant therapy, to diagnose various inherited conditions, such as hyperhomocystinemia, elevated factor
viii levels, dysfibrinogenemia, factor XII deficiency and disorders of plasmin generation, and to assess acquired conditions, such as pregnancy, postoperat...
VIII in Medical Dictionary
Thromboembolism
...with Warfarin against Recurrent Venous Thromboembolism Original Article from The New England Journal of Medicine -- High Plasma Levels of Factor
viii and the Risk of Recurrent Venous Thromboembolism Venous thromboembolism . BIBLIOGRAPHIC SOURCE(S) ... for venous thromboembolism are presen...
Hemophilia A
...ugh all ... Hemophilia A is characterized by deficiency in factor
viii clotting activity ... Individuals with moderately severe hemophilia A s... the gene. ... Patients with severe hemophilia A (hereditary factor
viii deficiency) continue ... It is possible that a significant number of hemop...
Hemophilia
...icle about haemophilia , a hereditary genetic illness that impairs the body's ability to control bleeding. Deficiency in coagulation factor
viii is the most common cause of hemophilia . ... Hemophilia is quite rare, with only about 1 instance in every 10,000 births (or ... In severe ...
Factor VIII assay
... Chromogenic assays for testing Factor
viii :C activity in plasma or concentrates, ... Factors Affecting the Factor
viii :C Reactivity When Tested in Purified Systems ... Factor
viii assay . Contents of this page: Alternative Names...
Compress
...LZ78. Professional software for the design and analysis of ASME Section
viii pressure vessels and heat exchangers. ... The COMPRESS 2008 Verification ...d ... Professional software for the design and analysis of ASME Section
viii pressure vessels and TEMA UHX heat exchangers. ... COMPRESS Overview ... ...
VIII in Biological News
Work in mice will contribute to the study of hereditary diseases that lead to blindness
...wise, some of the results obtained have been presented in oral communications and posters in different national and international scientific meetings:
viii European Meeting on Glial Cell Functions in Health and Disease (Londres), VII European Meeting on Glial Cell Functions in Health and Disease (Amsterda...
UT scientist receives hemophilia research award
...shortage of a blood-clotting protein called Factor
viii and current treatments include injections of synth...e systems that are resistant to replacement Factor
viii and produce antibodies that attack the synthetic p...lls that trigger the production of the anti-Factor
viii antibodies in people with Hemophilia A, which in t...
Removing DNA repair gene causes metabolic syndrome
...orts to clone and crystallize homologs to the Escherichia coli endonuclease
viii gene. E. coli endonuclease
viii is part of a pathway of enzymes involved in repairing DNA damaged by free r...
HIV inserts into human genome using a DNA-associated protein
...erapy delivery. Retroviral vectors are often used to introduce therapeutic genetic sequences into human chromosomes, such as in the delivery of Factor
viii for hemophilia patients.
HIV integrates into active transcription units on chromosomes within the nucleus of human cells. These units are sites th...
Promising therapies for haemophilia & heart disease
...Australian males is born with haemophilia in severe, moderate or mild form. People with haemophilia rely on intravenous infusion of recombinant Factor
viii clotting protein.
Professor Denisa Wagner and her Harvard colleagues have made ground-breaking discoveries that provide hope of an alternative treat...
Gene therapy advance treats hemophilia in mouse models
...o have Hemophilia A, which is also known as factor
viii deficiency. The findings appear in the Sept. 1 iss...mutation that leaves them with little to no factor
viii protein to prevent uncontrolled bleeding. Individu...therapy because if you could just raise the factor
viii activity from less than 1 percent of normal to wit...
Redesigned protein accelerates blood clotting
...reatment consists of genetically engineered factor
viii administered by injection, but one quarter of those born with no factor
viii suffer severe immune reactions that render the tre... Center have been studying the structure of factor
viii for 20 years, and are making subtle changes in the...
VIII in Biological Technology
China Biologic Receives SFDA Approval for Clinical Trial of Human Coagulation Factor VIII
TAIAN CITY, Shandong, China, Sept. 17 /Xinhua-PRNewswire-FirstCall/ --
China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic"
or the "Company"), one of the leading plasma-based pharmaceutical companies
in the People's Republic of China ("PRC"), today announced that the Comp...
Inspiration Biopharmaceuticals Presents Safety Data on IB1001, a Novel Recombinant Factor IX for the Treatment of Hemophilia at the International Society on Thrombosis and Haemostasis (ISTH) Annual Meeting
...cess of seven billion dollars annually. There are two types of hemophilia, hemophilia A and hemophilia B. Hemophilia A is caused by a lack of Factor
viii and hemophilia B is caused by a deficiency of Factor IX.
About Inspiration Biopharmaceuticals
Inspiration Biopharmaceuticals was found...
VIRxSYS Publishes New Study on RNA Therapy
...ed the liver to make more apoA-I protein than it normally does, and in separate experiments we instructed the liver to make the correct form of Factor
viii instead of a mutated form. We also added an RNA molecule that makes a monoclonal antibody that is not normally produced in liver," said VIRxSYS Execut...
Catalyst Biosciences Expands Scientific Advisory Board With Leading Experts in Protease Therapeutic Discovery and Development
...ers of thrombotic diseases, including the common human mutation Factor V Leiden. Studies of the bleeding disease combined deficiency of factors V and
viii by the Ginsburg lab identified mutations in two genes that define a novel pathway for the transport of a select subset of proteins from the ER to the ...
ThromboGenics and BioInvent Start Phase II Trial of TB-402, a Novel, Long Acting Anticoagulant for Deep Vein Thrombosis (DVT) Prophylaxis
...swire-FirstCall/ --
- Trial to Assess the Benefits of Partial Factor
viii Inhibition in
Patients Undergoing Knee Replacement Surgery
ThromboGe...iver important clinical benefits due to it
only partially inhibiting Factor
viii activity even when given in very high
doses. This novel mode of action is e...
Lentigen and Expression Therapeutics Sign Hemophilia Co-Development Agreement
...otting disorder caused by a mutation in the factor
viii gene resulting in a deficiency of factor
viii protein. Lentigen and Expression Therapeutics will...treatments for Hemophilia: a novel chimeric factor
viii protein for direct injection and a cell therapy th...
China Biologic Products Reports Strong Third Quarter 2008 Results
...eceived approval to commence clinical trial of Human Coagulation Factor
viii product ("FVIII"), a coagulation treatment for hemophilia and mass hemo... received SFDA approval for the clinical trials of Human Coagulation
Factor
viii ("FVIII"), a coagulation treatment for hemophilia and mass
hemorrhaging. It...
New Recombinant XYNTHA Now Available for Patients with Hemophilia A
...nt),
Plasma/Albumin-Free, a new recombinant factor
viii product for both the
control and prevention of ble...pments of the Company's current recombinant factor
viii product,
ReFacto(R) Antihemophilic Factor (Recombi...ophilia A are deficient in a key protein --
factor
viii -- that is vital in the clotting mechanism to prev...
CSL Behring's Innovative HeliTrax(SM) System Helps Physicians Manage Hemophilia A Patients
...-year-old son
Tyler's severe hemophilia and Factor
viii deficiency since October 2007.
"I love it," says...ate(R) FS
Helixate(R) FS is a recombinant factor
viii treatment for hemophilia A
that offers convenient ... with a 2.5 mL volume diluent; no
available factor
viii product has a smaller diluent size. The 2000 IU vi...
Video: CSL Behring Provides $1.2M Grant for World's First Study of Postpartum Women with VWD, Common Bleeding Disorder
...er they give birth."
In all women, von Willebrand factor (VWF) and factor
viii (FVIII)
levels increase throughout the third trimester and then decrease to...od, von Willebrand Factor: Ristocetin cofactor activity (VWF:RiCoF),
factor
viii (FVIII) and von Willebrand factor antigen (VWF:Ag) levels will
be measured....
VIII in Biological Products
VIII in Biological Definition
Collagen
...st interstitial tissue, assoc. with type I
Type VI collagen - most interstitial tissue, assoc. with type I
Type VII collagen - epithelia
Type
viii collagen - some endothelial cells
Type IX collagen - cartilage, assoc. with type II
Type X collagen - hypertrophic and mineralizing cartilage
...
VIII in Biological Dictionary
Stele
...mon. Smart Shopping at mySimon. Online Shopping at DirectTextBook.com - Save up to 80%, buy or rent. New and used books like La stele de Ptolemee
viii Evergete II a Heracleion Underwater Archaeology... stele . Definition from Wiktionary, a free dictionary. Jump to: navigation, search. See also s...
Nucleon
...ns ... the two- nucleon system, the ... Online Shopping at DirectTextBook.com - Save up to 80%, buy or rent. New and used books like Antiproton 86
viii European Symposium on Nucleon Antinucleon Interactions... butions of the nucleon , as well as the steady rate of improvements made in the ... n...
Lenticel
...on of lenticel , meaning of lenticel , lenticel anagrams, lenticel synonyms ... Words starting with lenticel by next letter. Words ... ISHS
viii International Mango Symposium EFFECT OF PACKHOUSE PROCEDURES ON LENTICEL DISCOLOURATION OF MANGOES ... can induce or reduce lenticel discolouratio...
Endonuclease
...f damaged ... IPR003651 Endonuclease III-like, iron ... Endonuclease
viii from <em>E. coli</em> acts as both an N-glycosylase and an AP-lyase. ... Endonuclease
viii Reaction Buffer (10X) Enzyme Properties. Heat ... <em>Tth</em&g...
Base modification
...ed . Yes, it is possible! ... I'm interested in all modification that will improve my quarter mile performance. ... ... Cohen's ride is a 98 Mark
viii Base model with a factory roof, heated seats, and ... He is in the automotive aftermarket industry and knew the dealer so he ... RNA Base Modi...